These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19938773)

  • 1. [Critical questions on diabetes therapy and their sequelae. HbA1c: may it be more than 7 after all?].
    Aumiller J
    MMW Fortschr Med; 2009 Oct; 151(42):14-6. PubMed ID: 19938773
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensified glucose control in type 2 diabetes--whose agenda?
    Yudkin JS; Richter B; Gale EA
    Lancet; 2011 Apr; 377(9773):1220-2. PubMed ID: 21093903
    [No Abstract]   [Full Text] [Related]  

  • 3. Type 2 diabetes: target HbA1c of about 7%.
    Prescrire Int; 2009 Aug; 18(102):177. PubMed ID: 19746575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetic complications: good metabolic control protects].
    MMW Fortschr Med; 2011 Apr; 153(15):44-5. PubMed ID: 21667560
    [No Abstract]   [Full Text] [Related]  

  • 5. [Typ 2 diabetes: glucose centered therapy is obsolete].
    Reincke M; Seissler J
    MMW Fortschr Med; 2008 May; 150(18):26-7. PubMed ID: 18533604
    [No Abstract]   [Full Text] [Related]  

  • 6. [Not Available].
    Zulewski H
    Ther Umsch; 2017; 74(8):411-416. PubMed ID: 29461143
    [No Abstract]   [Full Text] [Related]  

  • 7. [New diabetes guidelines in the EU and USA. Rigid HbA1c specifications are history!].
    Einecke D
    MMW Fortschr Med; 2012 Oct; 154(18):22, 24. PubMed ID: 23156863
    [No Abstract]   [Full Text] [Related]  

  • 8. Higher type 2 diabetes-related mortality when HbA1c levels are too low.
    Prescrire Int; 2008 Oct; 17(97):213. PubMed ID: 19536943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increased risk of hypoglycemia in the elderly and frail. Steep decrease of HbA1c is not always advisable].
    Pampel SL
    MMW Fortschr Med; 2011 Jul; 153(29-31):20. PubMed ID: 21830731
    [No Abstract]   [Full Text] [Related]  

  • 10. [Guidelines "Diabetes mellitus in the elderly"].
    Zeyfang A; Braun A
    MMW Fortschr Med; 2009 May; 151(20):33-5, 37. PubMed ID: 19728661
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term HbA1c stable. Insulin sensitizer keeps diabetes in check].
    MMW Fortschr Med; 2004 Mar; 146(13):60. PubMed ID: 15219138
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intensive blood glucose reduction: yes or no?].
    Bischoff A
    MMW Fortschr Med; 2015 Mar; 157(4):18-9. PubMed ID: 25743962
    [No Abstract]   [Full Text] [Related]  

  • 13. [Type 2 diabetes: early therapy intensification shows positive effects].
    MMW Fortschr Med; 2012 Sep; 154(16):70-1. PubMed ID: 23045941
    [No Abstract]   [Full Text] [Related]  

  • 14. Perioperative management of diabetic patients: new controversies.
    Aldam P; Levy N; Hall GM
    Br J Anaesth; 2014 Dec; 113(6):906-9. PubMed ID: 25080432
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rapid disease progression, early insulin requirement].
    Einecke D
    MMW Fortschr Med; 2012 Jun; 154(12):26. PubMed ID: 22880292
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin therapy in patients with type 2 diabetes].
    Siegmund T; Schumm-Draeger PM
    MMW Fortschr Med; 2008 May; 150(18):32-5; quiz 36. PubMed ID: 18533606
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diabetes in old age--risk by over- and undertreatment].
    Zeyfang A; Bahrmann A
    MMW Fortschr Med; 2013 Jul; 155(13):56-8. PubMed ID: 23964510
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
    Monami M; Candido R; Pintaudi B; Targher G; Mannucci E;
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2539-2546. PubMed ID: 34158243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines ease up on glycemic control for some patients with type 2 diabetes.
    Mitka M
    JAMA; 2012 Jun; 307(21):2243-4. PubMed ID: 22706812
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk.
    Wareham NJ; Pfister R
    Nat Rev Cardiol; 2010 Jul; 7(7):367-8. PubMed ID: 20577298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.